Older women with early-stage breast cancer face significant cardiovascular mortality risk, highlighting the need for effective cardiovascular preventive therapy.
Cardiovascular death is a significant competing risk in older women with early-stage breast cancer, highlighting the need for cardiovascular preventive therapy.
Absolute Event Rate: 0% vs 0%
Cardiovascular death is an important competing risk for older women with early-stage breast cancer. This finding mandates adequate attention to cardiovascular preventive therapy after diagnosis of breast cancer.
Abdel‐Qadir et al. (Wed,) reported a other. Older women with early-stage breast cancer face significant cardiovascular mortality risk, highlighting the need for effective cardiovascular preventive therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: